130 related articles for article (PubMed ID: 16048441)
1. Influence of depression and HIV serostatus on the neuropsychological performance of injecting drug users.
Waldrop-Valverde D; Ownby RL; Kumar M
Psychiatry Clin Neurosci; 2005 Aug; 59(4):372-8. PubMed ID: 16048441
[TBL] [Abstract][Full Text] [Related]
2. Depressive disorders and suicide attempts in injecting drug users with and without HIV infection.
Malbergier A; de Andrade AG
AIDS Care; 2001 Feb; 13(1):141-50. PubMed ID: 11177471
[TBL] [Abstract][Full Text] [Related]
3. Depression as measured by the Beck Depression Inventory-II among injecting drug users.
Johnson ME; Neal DB; Brems C; Fisher DG
Assessment; 2006 Jun; 13(2):168-77. PubMed ID: 16672731
[TBL] [Abstract][Full Text] [Related]
4. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.
Gibbie T; Mijch A; Ellen S; Hoy J; Hutchison C; Wright E; Chua P; Judd F
HIV Med; 2006 Mar; 7(2):112-21. PubMed ID: 16420256
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study.
Justice AC; McGinnis KA; Atkinson JH; Heaton RK; Young C; Sadek J; Madenwald T; Becker JT; Conigliaro J; Brown ST; Rimland D; Crystal S; Simberkoff M;
AIDS; 2004 Jan; 18 Suppl 1():S49-59. PubMed ID: 15075498
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive aspects of medication adherence in HIV-positive injecting drug users.
Waldrop-Valverde D; Ownby RL; Wilkie FL; Mack A; Kumar M; Metsch L
AIDS Behav; 2006 May; 10(3):287-97. PubMed ID: 16485072
[TBL] [Abstract][Full Text] [Related]
7. The effects of low literacy and cognitive impairment on medication adherence in HIV-positive injecting drug users.
Waldrop-Valverde D; Jones DL; Weiss S; Kumar M; Metsch L
AIDS Care; 2008 Nov; 20(10):1202-10. PubMed ID: 19012081
[TBL] [Abstract][Full Text] [Related]
8. Serial position effects in HIV-infected injecting drug users.
Waldrop D; Ownby RL; Kumar M
Int J Neurosci; 2004 Apr; 114(4):493-516. PubMed ID: 15195354
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users.
Hestad K; Aukrust P; Ellertsen B; Kløve H; Wilberg K
J Clin Exp Neuropsychol; 1993 Sep; 15(5):732-42. PubMed ID: 8276932
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological impairment among asymptomatic HIV-positive former intravenous drug users.
Rodríguez Salgado D; Rodríguez Alvarez M; Seoane Pesqueira G
Cogn Behav Neurol; 2006 Jun; 19(2):95-104. PubMed ID: 16783132
[TBL] [Abstract][Full Text] [Related]
11. Coping among HIV negative and HIV positive female injection drug users.
Brook DW; Brook JS; Whiteman M; Roberto J; Masci JR; Amundsen F; de Catalogne J
AIDS Educ Prev; 1999 Jun; 11(3):262-73. PubMed ID: 10407459
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological performance in HIV/AIDS intravenous drug users.
Vazquez-Justo E; Rodríguez Alvarez M; Carro Ramos J
J Clin Exp Neuropsychol; 2003 Sep; 25(6):852-65. PubMed ID: 13680462
[TBL] [Abstract][Full Text] [Related]
13. Predictors of mortality among injecting and non-injecting HIV-negative drug users in northern Thailand.
Quan VM; Vongchak T; Jittiwutikarn J; Kawichai S; Srirak N; Wiboonnatakul K; Razak MH; Suriyanon V; Celentano DD
Addiction; 2007 Mar; 102(3):441-6. PubMed ID: 17298652
[TBL] [Abstract][Full Text] [Related]
14. Demographic characteristics and risk behaviors associated with HIV positive injecting drug users in Xinjiang, China.
Zhang Y; Shan H; Trizzino J; Ruan Y; Beauchamp G; Mâsse B; Ma J; Gu Y; He Y; Rui B; Wang J; Poundstone K; Jiang Y; Brooks Jackson J; Shao Y
J Infect; 2007 Mar; 54(3):285-90. PubMed ID: 16831464
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of unprotected sex among Finnish HIV-positive and HIV-negative injecting drug users.
Kivelä PS; Krol A; Partanen AL; Ristola MA
Scand J Public Health; 2009 Jun; 37(4):357-63. PubMed ID: 19372233
[TBL] [Abstract][Full Text] [Related]
16. HIV prevalence and factors associated with HIV infection among male injection drug users under 30: a cross-sectional study in Long An, Vietnam.
Tran TM; Nguyen HT; Yatsuya H; Hamajima N; Nishimura A; Ito K
BMC Public Health; 2006 Oct; 6():248. PubMed ID: 17029648
[TBL] [Abstract][Full Text] [Related]
17. Coping strategies of HIV-positive and HIV-negative female injection drug users: a longitudinal study.
Brook DW; Brook JS; Richter L; Whiteman M; Win PT; Masci JR; Roberto J
AIDS Educ Prev; 1999 Oct; 11(5):373-88. PubMed ID: 10555622
[TBL] [Abstract][Full Text] [Related]
18. Influence of depressed mood on neuropsychologic performance in HIV-seropositive drug users.
Vázquez-Justo E; Rodríguez Alvarez M; Ferraces Otero MJ
Psychiatry Clin Neurosci; 2003 Jun; 57(3):251-8. PubMed ID: 12753563
[TBL] [Abstract][Full Text] [Related]
19. Suicide probability and psychological morbidity secondary to HIV infection: a control study of HIV-seropositive, hepatitis C virus (HCV)-seropositive and HIV/HCV-seronegative injecting drug users.
Grassi L; Mondardini D; Pavanati M; Sighinolfi L; Serra A; Ghinelli F
J Affect Disord; 2001 May; 64(2-3):195-202. PubMed ID: 11313086
[TBL] [Abstract][Full Text] [Related]
20. Young adult injection drug users in the United States continue to practice HIV risk behaviors.
Rondinelli AJ; Ouellet LJ; Strathdee SA; Latka MH; Hudson SM; Hagan H; Garfein RS
Drug Alcohol Depend; 2009 Sep; 104(1-2):167-74. PubMed ID: 19559543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
